Copyright
©The Author(s) 2025.
World J Diabetes. Mar 15, 2025; 16(3): 102899
Published online Mar 15, 2025. doi: 10.4239/wjd.v16.i3.102899
Published online Mar 15, 2025. doi: 10.4239/wjd.v16.i3.102899
Table 2 Characteristics, advantages, disadvantages, and usage of common antidiabetic drugs
Drug name | Advantages | Disadvantages | Usage | Applicable patients and considerations |
Metformin | Significantly lowers HbA1c levels; aids in weight reduction; reduces cardiovascular event risks | May cause gastrointestinal discomfort (e.g., diarrhea, nausea); use with caution in patients with renal impairment due to the risk of lactic acidosis | Typically taken orally, recommended during or after meals to reduce gastrointestinal side effects | Preferred for overweight or obese patients with type 2 diabetes, especially those at high risk of cardiovascular disease |
Sulfonylureas | Rapidly lower blood glucose levels; convenient, often once-daily dosing | Risk of hypoglycemia; may cause weight gain | Usually taken before meals, with the dosage adjusted based on blood glucose levels | Suitable for patients without a high risk of hypoglycemia; attention needed for weight management in obese patients |
DPP-4 inhibitors | Reduce HbA1c levels with minimal risk of hypoglycemia; minimal impact on weight | Relatively weaker glucose-lowering effect; potential risk of pancreatitis | Taken orally, typically once daily | Suitable for patients struggling with weight management or at risk of hypoglycemia, particularly elderly patients and those with chronic kidney disease |
GLP-1 receptor agonists | Promote weight loss and improve cardiovascular health; significantly lower HbA1c levels | Require injection, which may reduce patient compliance; may cause gastrointestinal discomfort (e.g., nausea, vomiting) | Administered subcutaneously, usually weekly or daily depending on the drug type | Ideal for obese patients needing weight management and those with type 2 diabetes and cardiovascular diseases |
Insulin | Effectively controls hyperglycemia and suitable for all types of diabetes; flexible dosage adjustments | Risk of hypoglycemia and weight gain; requires patient education and regular blood glucose monitoring | Administered subcutaneously, with dosage adjustments based on blood glucose levels and dietary intake | Suitable for patients with severe conditions or inadequate control with other medications, especially those with type 1 diabetes or gestational diabetes |
- Citation: Li ZP, Sun JK, Fu WP, Zhang CJ. Optimizing risk management for post-amputation wound complications in diabetic patients: Focus on glycemic and immunosuppressive control. World J Diabetes 2025; 16(3): 102899
- URL: https://www.wjgnet.com/1948-9358/full/v16/i3/102899.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i3.102899